Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells
Martin Schlaeth, Sven Berger, Stefanie Derer, Katja Klausz, Stefan Lohse, Michael Dechant, Greg A. Lazar, Tanja Schneider-Merck, Matthias Peipp, Thomas ValeriusVolume:
101
Year:
2010
Language:
english
Pages:
9
DOI:
10.1111/j.1349-7006.2010.01505.x
File:
PDF, 619 KB
english, 2010